靶点针对疾病信息19(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T59604
TARGNAME
Growth hormone secretagogue receptor 1 (GHSR)
INDICATI
Approved Chronic pain [ICD-11: MG30]
INDICATI
Approved Pituitary gland disorder [ICD-11: 5A60-5A61]
INDICATI
Phase 3 Inborn carbohydrate metabolism error [ICD-11: 5C51]
INDICATI
Phase 2b Digestive system disease [ICD-11: DE2Z]
INDICATI
Phase 2b Gastroduodenal motor/secretory disorder [ICD-11: DA41]
INDICATI
Phase 2b Small intestine motility disorder [ICD-11: DA93]
INDICATI
Phase 2 Old age [ICD-11: MG2A]
INDICATI
Phase 1/2 Postoperative ileus [ICD-11: DA91-DB30]
INDICATI
Phase 1 Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Phase 1 Type 2 diabetes mellitus [ICD-11: 5A11]
INDICATI
Discontinued in Phase 1/2 Obesity [ICD-11: 5B80-5B81]
INDICATI
Preclinical Metabolic disorder [ICD-11: 5C50-5D2Z]
INDICATI
Preclinical Substance abuse [ICD-11: 6C40]
INDICATI
Terminated Anorexia nervosa [ICD-11: 6B80]
INDICATI
Investigative Cachexia [ICD-11: MG20]
INDICATI
Investigative Oesophagus motility disorder [ICD-11: DA21]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3